EPISODE · Sep 9, 2024 · 9 MIN
1943: Interview with CEO Martin Gouldstone of Oncimmune
from The Vox Markets Podcast · host Vox Markets Podcast
In this upbeat interview, CEO Martin Gouldstone of Oncimmune - a leading life sciences firm providing autoantibody profiling services that are used to enable precision medicine within the Biopharma industry – takes me through today’s positive yearend trading update, 3 contract wins and exciting road ahead.
NOW PLAYING
1943: Interview with CEO Martin Gouldstone of Oncimmune
0:00
9:22
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The Vox Markets Podcast?
This episode is 9 minutes long.
When was this The Vox Markets Podcast episode published?
This episode was published on September 9, 2024.
What is this episode about?
In this upbeat interview, CEO Martin Gouldstone of Oncimmune - a leading life sciences firm providing autoantibody profiling services that are used to enable precision medicine within the Biopharma industry – takes me through today’s positive...
Can I download this The Vox Markets Podcast episode?
Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!